Explore more publications!

Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

Press releases published on January 7, 2026

Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform
National Institutes of Health Awards $1.54M Grant To  Scottish Rite for Children for Rare Diseases Research
ENT & Allergy Associates Welcomes Otolaryngologist Christopher V. Lisi, MD to its West Nyack, NY Office
Cullgen Announces Conference Participation During J.P. Morgan Healthcare Conference Week
Scottish Rite for Children Receives $2.3M NIH Grant to Advance  Bone Regeneration Research in Children With Perthes Disease
USOSM Continues Growth Momentum
CERo Therapeutics Provides Clinical Update on Phase 1  Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Betterguards Broadens Global Reach with Canadian Expansion
FemPulse Positive Clinical Data To Be Presented at SUFU Conference
VIVUS Introduces Lower Pricing on QSYMIA® at Costco Locations Across Hawaii
Weight Watchers to Participate in Upcoming Investor Conferences
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
Pulmocide Announces Termination of Opera-T Phase 3 Study with Opelconazole
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
Sofwave Medical Reports Preliminary, Unaudited, Fourth Quarter and Full Fiscal Year 2025 Topline Financial Results
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adherence and persistence
EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions